Literature DB >> 2558370

Chemotherapy in lung cancer.

C G Price1, M L Slevin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2558370      PMCID: PMC2429318          DOI: 10.1136/pgmj.65.763.291

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  44 in total

1.  A randomized trial comparing vindesine and cisplatinum to vindesine and methotrexate in advanced non small cell lung carcinoma.

Authors:  V J Harvey; M L Slevin; S P Cheek; M J Barnett; W Gregory; J P Thompson; P F Wrigley
Journal:  Eur J Cancer Clin Oncol       Date:  1987-11

2.  Vincristine and etoposide: an effective chemotherapy regimen with reduced toxicity in extensive small-cell lung cancer.

Authors:  D A Morgan; D Gilson; J Fletcher
Journal:  Eur J Cancer Clin Oncol       Date:  1987-06

Review 3.  Quality of life in patients with non-small cell lung cancer treated with chemotherapy.

Authors:  R Feld
Journal:  Eur J Cancer Clin Oncol       Date:  1987-04

4.  Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada.

Authors:  W K Evans; R Feld; N Murray; A Willan; P Coy; D Osoba; F A Shepherd; D A Clark; M Levitt; A MacDonald
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

5.  Tumor markers in small cell lung cancer.

Authors:  H H Hansen; M Hansen
Journal:  Eur J Cancer Clin Oncol       Date:  1987-11

6.  Prognostic factors in small cell lung cancer: a simple prognostic index is better than conventional staging.

Authors:  M D Vincent; S E Ashley; I E Smith
Journal:  Eur J Cancer Clin Oncol       Date:  1987-11

7.  Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial.

Authors:  K Havemann; M Wolf; R Holle; C Gropp; P Drings; H G Manke; K Hans; M Schroeder; M Heim; N Victor
Journal:  Cancer       Date:  1987-03-15       Impact factor: 6.860

8.  Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung.

Authors:  M C Perry; W L Eaton; K J Propert; J H Ware; B Zimmer; A P Chahinian; A Skarin; R W Carey; H Kreisman; C Faulkner
Journal:  N Engl J Med       Date:  1987-04-09       Impact factor: 91.245

9.  Carboplatin (Paraplatin; JM8) and etoposide (VP-16) as first-line combination therapy for small-cell lung cancer.

Authors:  I E Smith; B D Evans; M E Gore; M D Vincent; L Repetto; J R Yarnold; H T Ford
Journal:  J Clin Oncol       Date:  1987-02       Impact factor: 44.544

10.  Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer.

Authors:  M H Bronchud; J H Scarffe; N Thatcher; D Crowther; L M Souza; N K Alton; N G Testa; T M Dexter
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.